The effectiveness of ritonavir-boosted nirmatrelvir (NMV-r) against Omicron variants.
Novartis’ simplified strategy takes shape as the company seeks former Bristol Myers CEO as chair
Novartis appears headed in the right direction now that Sandoz has been spun out, operations have been streamlined and the Swiss company is reporting higher-than-expected